SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+6.52%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$324M
AUM Growth
+$324M
(+8.2%)
Cap. Flow
+$11.1M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$9.59M |
| 2 |
Innoviva
INVA
|
$1.55M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 59.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $120M | 37.1% | 383,858 | – | – |
|
|
MDCO
2
DELISTED
Medicines Co
MDCO
| $64.9M | 20.03% | 1,752,000 | – | – |
|
|
3
Innoviva
INVA
$1.29B
| $50.8M | 15.69% | 3,600,705 +110,000 | +3% | +$1.55M |
|
|
ACHN
4
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $9.59M | 2.96% | +2,136,800 | New | +$9.59M |
|
|
NVLN
5
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $7.21M | 2.22% | 1,025,000 | – | – |
|
|
SEEL
6
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $2.48M | 0.76% | 1,447,906 | – | – |
|
|
ADXS
7
DELISTED
Advaxis, Inc.
ADXS
| $1.42M | 0.44% | 339,180 | – | – |
|
8
AbbVie
ABBV
$372B
| $888K | 0.27% | 10,000 | – | – |
|